Literature DB >> 10197839

Phytotherapy in the treatment of benign prostatic hyperplasia: an update.

F C Lowe1, E Fagelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10197839     DOI： 10.1016/s0090-4295(98)00664-5

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  12 in total

Review 1.  Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.

Authors:  K Dreikorn
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

2.  Towards the prevention and management of prostatic diseases in Nigeria: a framework.

Authors:  Chukwunonso Ecc Ejike
Journal:  Malays J Med Sci       Date:  2011-07

3.  A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

Authors:  Fatih Hizli; M Cemil Uygur
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

4.  [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

Review 5.  Saw palmetto and lower urinary tract symptoms: what is the latest evidence?

Authors:  Andrew L Avins; Stephen Bent
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

6.  The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States.

Authors:  David A Taub; John T Wei
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

7.  Saw Palmetto Berry as a Treatment for BPH.

Authors:  E Fagelman; F C Lowe
Journal:  Rev Urol       Date:  2001

8.  Quality of life and sexual function in patients with benign prostatic hyperplasia.

Authors:  Reginald C Bruskewitz
Journal:  Rev Urol       Date:  2003

Review 9.  Phytotherapy for chronic prostatitis.

Authors:  F C Lowe; E Fagelman
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

10.  Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH).

Authors:  Angelo J Cambio; Christopher P Evans
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.